Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -11.00 -2.59% 414.50 227,351 16:29:45
Bid Price Offer Price High Price Low Price Open Price
413.50 414.50 423.00 394.00 421.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 12.84 -53.67 -12.55 1,185
Last Trade Time Trade Type Trade Size Trade Price Currency
17:53:59 O 3,712 414.668 GBX

Puretech Health (PRTC) Latest News

More Puretech Health News
Puretech Health Investors    Puretech Health Takeover Rumours

Puretech Health (PRTC) Discussions and Chat

Puretech Health Forums and Chat

Date Time Title Posts
02/3/202118:30PureTech Health - innovative healthcare1,187
22/7/201820:35PureTech Health (PRTC) One to Watch Monday -

Add a New Thread

Puretech Health (PRTC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Puretech Health trades in real-time

Puretech Health (PRTC) Top Chat Posts

Puretech Health Daily Update: Puretech Health Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 425.50p.
Puretech Health Plc has a 4 week average price of 365.50p and a 12 week average price of 295p.
The 1 year high share price is 446p while the 1 year low share price is currently 198.50p.
There are currently 285,898,746 shares in issue and the average daily traded volume is 326,954 shares. The market capitalisation of Puretech Health Plc is £1,185,050,302.17.
volvo: The the doubling action on VOR and the Karuna topping $120 added quite literally added over $100m to Puretech as additional assets....UK market gives it $ VOR plus Karuna $520m, thats insane Vedanta IPO is already eagerly awaiting, more than VOR is/was. Vedanta could see $1 billion added to Puretech's coffers at launch.....or £730m nearly 3/4 the share price, because anyone can see nothing is in the share price yet
volvo: Watching the LSE share price action this week has been facinating. We are being held atm, obviously got $360m min cash and over $300m in Karuna shares. News this week that the Vedanta IPO looks imminent, more tangible shares and cash. Also from the recent presentations, where it was made clear up to six of the founded entities could look for IPO's in the next 12 months. Value everywhere you look. Maybe someone wants a punt here, just need to get the Ivesco shares on board?
volvo: More director buys, clearly making a sign....Chowrira is another super well connected pharma man. lmaf....last broker target price was 483p obviously ignored by the LSE like it does with everthing PRTC. Vedanta IPO will move the share price I'm reliably informed to 400p plus. Only a few week away too.
volvo: To give some valuation expectation. With Karuna, PRTC's share price went from 163p to 270p from the IPO announcment to listing and its basically hung around here ever since. This time with Vedanta there is no need to sell stock. Anticipate similar rise to 400p plus from IPO announcement. Yesterdays RNS made it clear what the new man Troy does...he arrived at Karuna in March and IPO announced in April. ....Mr. Ignelzi has played a key role in seven IPOs, and currently serves as the chief financial officer of Karuna Therapeutics. He joined Karuna in March 2019, coming from scPharmaceuticals, where he was also in the role of chief financial officer overseeing its transformation to a company preparing for commercial launch.
volvo: Daphne spells it out at 5 minutes into her Credit Suisse presention last Thursday..... abridged version.... The board of directors can see a clear share price disconnect between our achievements to date and our share price, blames directly the London listing for the SIGNIFICANT discount, then compares the cash of $387m and the 12 pc stake in Karuna $350 as virtually equating to the current share price so everything else for free, 8 founded entities, and the associated royalties and all of the wholly owned pipeline, THEN she says that is why they are listed on the NASDAQ to achieve proper market value Listen to it and sit back and imagine how high the shares will go in the USA. Daphne is beating the drum and rightly so.
deadly nightshade: excellent thanks volvo roll on monday i can't wait, be good if we can see the back of these ii's then hopefully after the share price will find its true level rather then constant selling by them into any rise that way hindering the share price
deadly nightshade: volvo you are up to speed here, would you have a rough idea come monday how this dual listing will work in the sense that when nasdaq starts trading how will it work if say americans want a chunk of shares, how many prtc shares are american brokers holding at first bell to sell into the market?? or will they have to come calling for more across the pond and that way share price potentially rises fast to accomodate the demand? or could it be they might be sitting on a chunk off ii's shares ready to sell into the nasdaq market at a price??
lendmeafiver: what the PRTC Share Price?
lendmeafiver: Further good news flow here today and KRTX looking solid, whilst the PRTC share price seems to be all over the place on minimal volume.
lendmeafiver: Agree. Surely given recent progress an ipo or other transaction at Gelesis has to be on the cards, will have a huge impact on the Prtc share price I expect.
Puretech Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Puretech H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210307 19:04:25